Lexeo Therapeutics, Inc. (LXEO) Stock News & Chart | StockAdder

(LXEO)

Lexeo Therapeutics, Inc.

Stock chart and latest news for Lexeo Therapeutics, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Lexeo Therapeutics, Inc. News

PRO

Suvretta, Averill disclose multi-million share holdings in Lexeo Therapeutics (NASDAQ: LXEO)

Apr 13, 2026 ChartMill

LXEO News | LEXEO THERAPEUTICS INC (NASDAQ:LXEO)

Apr 10, 2026 Yahoo Finance

Wall Street Rallies Behind Lexeo Therapeutics (LXEO)’s Gene Therapy Pipeline

Dec 27, 2025 Sahm

Insiders In Lexeo Therapeutics Left Out From 14% Price Rise After Disposing Stock

Apr 9, 2026 TradingView — Track All Markets

LXEO Stock Price and Chart — NASDAQ:LXEO

Nov 25, 2025 Quiver Quantitative

LEXEO THERAPEUTICS Q4 2025 Earnings Preview: Recent $LXEO Insider Trading, Hedge Fund Activity, and More

Mar 13, 2026 GlobeNewswire

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Mar 30, 2026 Investing.com

Lexeo Therapeutics stock falls after PKP2 gene therapy data

Jan 12, 2026 The Globe and Mail

Oppenheimer Reaffirms Their Buy Rating on Lexeo Therapeutics, Inc. (LXEO)

Apr 1, 2026 Stock Titan

Lexeo says cash lasts into 2028 as pivotal gene therapy trial nears

Mar 30, 2026 Yahoo Finance

Will Lexeo Therapeutics (NASDAQ:LXEO) Spend Its Cash Wisely?

Apr 1, 2026 simplywall.st

Institutional investors have a lot riding on Lexeo Therapeutics, Inc. (NASDAQ:LXEO) with 56% ownership